Virtus Fund Advisers’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $44.8K | Buy |
2,724
+94
| +4% | +$1.55K | 0.14% | 75 |
|
|
2024
Q3 | $65K | Hold |
2,630
| – | – | 0.26% | 47 |
|
|
2024
Q2 | $66.6K | Buy |
2,630
+71
| +3% | +$1.8K | 0.26% | 40 |
|
|
2024
Q1 | $65K | Buy |
+2,559
| New | +$65K | 0.23% | 48 |
|
|
2023
Q4 | – | Sell |
-3,490
| Closed | -$65K | – | 106 |
|
|
2023
Q3 | $65K | Hold |
3,490
| – | – | 0.46% | 31 |
|
|
2023
Q2 | $90.7K | Hold |
3,490
| – | – | 0.64% | 19 |
|
|
2023
Q1 | $100K | Hold |
3,490
| – | – | 0.7% | 17 |
|
|
2022
Q4 | $103K | Buy |
+3,490
| New | +$103K | 0.74% | 14 |
|
|
2015
Q2 | – | Sell |
-20,836
| Closed | -$858K | – | 855 |
|
|
2015
Q1 | $858K | Sell |
20,836
-1,931
| -8% | -$79.5K | 0.01% | 364 |
|
|
2014
Q4 | $928K | Buy |
22,767
+110
| +0.5% | +$4.48K | 0.01% | 376 |
|
|
2014
Q3 | $831K | Sell |
22,657
-1,071
| -5% | -$39.3K | 0.01% | 403 |
|
|
2014
Q2 | $1.1M | Buy |
+23,728
| New | +$1.1M | 0.01% | 439 |
|